Request Deal Involvement
Sanofi completed the acquisition of Kymab from Malin and Schroder for $1.1bn.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
pr advisors
Consilium Strategic Communications
legal advisors
Goodwin Procter
financial advisors
JP Morgan
legal advisors
Weil Gotshal and Manges
pr advisors
Powerscourt
brokers
Liberum Capital
brokers
Davy Corporate Finance
or
Principals
target
KYMAB
bidder
SANOFI SA
vendor
MALIN CORPORATION PLC
vendor
SCHRODER UK PUBLIC PRIVATE TRUST PLC
vendor
BILL AND MELINDA GATES FOUNDATION
vendor
ORI CAPITAL
vendor
THE WELLCOME TRUST
vendor
LIFEARC VENTURES
vendor
SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite